Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway

Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway

US Patent 12018080 · Granted Jun 25, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Techniques for joint demodulation via proximity services2025
Adaptive determination of constellation point usage probabilities2025
Interference rejection combining using precoding resource group parameter2025
Adaptive power allocation for TX antenna based on enhanced CSF report2025
Signal-to-noise ratio balancing using singular value combiner precoder matrices2025
Modulation of novel immune checkpoint targets2025
Compositions and methods using an epigenetic inhibitor2025
Signaling of network entities' phase noise inter-carrier interference order for 2025
Demodulation reference signal sharing across user equipments (UEs) supporting ov2025
Methods for predicting outcomes and treating colorectal cancer using a cell atla2025
Methods and compositions for modulating innate lymphoid cell pathogenic effector2025
Frequency dependent residual sideband indications2025